Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women

Table 2

Comparison of baseline biochemical and hormonal parameters of patient groups.

	GROUP 1-COC; ()	GROUP 2-MYO; ()
Fasting glucose (mg/dL)			0.535
Fasting insulin (μIU/dL)			0.626
HOMA-IR			0.649
HDL (mg/dL)			0.731
LDL (mg/dL)			0.149
TG (mg/dL)			0.942
Total cholesterol (mg/dL)			0.636
CRP (mg/L)			0.437
Apo B/A1			0.537
DHEAS (μg/dL)			0.644
C-peptide (ng/mL)			0.461
Total testosterone (ng/dL)			0.573
Free testosterone (pg/mL)			0.176
Androstenedione (ng/mL)			0.397
17-OH progesterone (ng/mL)			0.119
SHBG (nmol/L)			0.010
Progesterone (ng/mL)			0.824
Estradiol (pg/mL)			0.102

COC: combined oral contraceptives; MYO: myoinositol + folic acid; HOMA-IR: Homeostatic Model Assessment-Insulin Resistance; HDL: high density lipoprotein; LDL: low density lipoprotein; TG: triglyceride; CRP: C-reactive protein; Apo B/A1: apoprotein B/A1; DHEAS: dehydroepiandrosterone sulfate; SHBG: sex hormone binding globulin; FSH: follicular stimulating hormone; LH: luteinizing hormone; TSH: thyroid stimulating hormone; AMH: anti-Mullerian hormone. Independent -test.